Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Garber

Showing results (161-170 of 194) with videos related to

Pageof 20
Sort By:
Nature Biotechnology|November 8, 2005
First-in-class biologic to enter rheumatoid arthritis frayKen Garber
Science (New York, N.Y.)|December 19, 2009
Cancer research. Melanoma drug vindicates targeted approachKen Garber
Nature Biotechnology|December 17, 2009
Proteostasis therapeuticsKen Garber
Nature Biotechnology|December 10, 2015
Predictive biomarkers for checkpoints, first tests approvedKen Garber
Nature Biotechnology|December 10, 2015
Tumor macrophage target fuels $1.7-billion dealKen Garber
Journal of the National Cancer Institute|September 22, 2005
Human Cancer Genome Project moving forward despite some doubts in communityKen Garber
Journal of the National Cancer Institute|April 5, 2007
Users fear that lymphoma drugs will disappearKen Garber
American Heritage of Invention & Technology|December 7, 2006
The clot stopperKen Garber
Nature Biotechnology|July 15, 2006
Patently absurd?Ken Garber
Journal of the National Cancer Institute|December 7, 2006
New method found to trigger cancer cell suicideKen Garber
Pageof 20

Showing results (161-170 of 194) with videos related to

Sort By:
Pageof 20
Nature Biotechnology|November 8, 2005
First-in-class biologic to enter rheumatoid arthritis frayKen Garber
Science (New York, N.Y.)|December 19, 2009
Cancer research. Melanoma drug vindicates targeted approachKen Garber
Nature Biotechnology|December 17, 2009
Proteostasis therapeuticsKen Garber
Nature Biotechnology|December 10, 2015
Predictive biomarkers for checkpoints, first tests approvedKen Garber
Nature Biotechnology|December 10, 2015
Tumor macrophage target fuels $1.7-billion dealKen Garber
Journal of the National Cancer Institute|September 22, 2005
Human Cancer Genome Project moving forward despite some doubts in communityKen Garber
Journal of the National Cancer Institute|April 5, 2007
Users fear that lymphoma drugs will disappearKen Garber
American Heritage of Invention & Technology|December 7, 2006
The clot stopperKen Garber
Nature Biotechnology|July 15, 2006
Patently absurd?Ken Garber
Journal of the National Cancer Institute|December 7, 2006
New method found to trigger cancer cell suicideKen Garber
Pageof 20